Search research articles
Contact Us
Filters
Showing results (111-120 of 127) with videos related to
Page
of 13
Sort By:
Neuro-Oncology
|
April 5, 2013
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma
Andrew D Norden, Glenn J Lesser, Jan Drappatz, et al.
The Oncologist
|
June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases
Richard S P Huang, James Haberberger, Kimberly McGregor, et al.
NEJM Evidence
|
March 13, 2023
Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment
W Gregory Hundley, Ralph D'Agostino, Teresa Crotts, et al.
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Patrick Y Wen, David A Reardon, Terri S Armstrong, et al.
Journal of Neuro-Oncology
|
October 23, 2014
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas
Andrew D Norden, David Schiff, Manmeet S Ahluwalia, et al.
Oncotarget
|
October 13, 2025
Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields
Hugo Jimenez, Denise Gibo, Sambad Sharma, et al.
Neurology
|
December 21, 2014
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma
Andrew D Norden, Keith L Ligon, Samantha N Hammond, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
Neuro-Oncology
|
January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
Eudocia Q Lee, Michael Weller, Joohee Sul, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 127) with videos related to
Sort By:
Page
of 13
Neuro-Oncology
|
April 5, 2013
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma
Andrew D Norden, Glenn J Lesser, Jan Drappatz, et al.
The Oncologist
|
June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases
Richard S P Huang, James Haberberger, Kimberly McGregor, et al.
NEJM Evidence
|
March 13, 2023
Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment
W Gregory Hundley, Ralph D'Agostino, Teresa Crotts, et al.
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Patrick Y Wen, David A Reardon, Terri S Armstrong, et al.
Journal of Neuro-Oncology
|
October 23, 2014
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas
Andrew D Norden, David Schiff, Manmeet S Ahluwalia, et al.
Oncotarget
|
October 13, 2025
Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields
Hugo Jimenez, Denise Gibo, Sambad Sharma, et al.
Neurology
|
December 21, 2014
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma
Andrew D Norden, Keith L Ligon, Samantha N Hammond, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
Neuro-Oncology
|
January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
Eudocia Q Lee, Michael Weller, Joohee Sul, et al.
Page
of 13